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VMAT delivery. Our next step is to acquire a real tumor trajectory for 
a lung cancer patient using a 320-row CT, which will be fed into the 
phantom controller for our further validation.  
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Purpose/Objective: Kilovoltage cone-beam CT (CBCT) devices allow 
image guidance before radiotherapy treatments. Cone beam 
introduces more scatter radiation than a conventional CT scanner. In 
this study, the more suitable Cone Beam Dose index (CBDI) was 
measured instead of CT Dose Index (CTDI), in order to have a better 
evaluation of the average volumetric dose from the CBCT in the CTDI 
phantom. CBDI was measured and used to estimate organ and 
effective doses from CBCT using two MonteCarlo software. 
Materials and Methods: Three standard CTDI head phantoms and a 
Farmer chamber (according tothe AAPM Report 111) were used to 
measure the CBDI form an Elekta XVI (ver.4.2.1). The CBDI 
measurements were performed using two protocols. Protocol 1 is used 
in clinics to verify patient setup in the treatment room.The 
parameters are: 36.1 mAs, 100 kV, 200° rotation angle and S20 
collimator (small FOV). Protocol 2 is the one we use for replanning to 
obtain a better image quality. It works with 647 mAs, 120 kV, 360° 
rotation angle and M20 collimator (medium FOV). The scatter 
contribution on the CBDI was measured using two phantom set-ups 
and the Protocol 2. In the first setup the chamber is placed in the 
central hole of one phantom. In the second set-up the chamber was 
inserted in the central phantom of three aligned in the longitudinal 
direction. This configuration was used as reference for dose 
simulation because it better simulates the patient scatter conditions, 
and the CBDIw was calculated using the formula 
CBDIw=1/3CBDIcenter+2/3CBDIperiphery.  
Two simulation software requiring different input parameters were 
used for the estimation of the effective and organs at risk dose in the 
Head&Neck district. CTDosimetry software (ver. 1.0.4 ImPACT, 
London, UK)uses the CBDIw measurement with mAs, kV and scan 
region. PCXMC2.0Rotationsoftware (STUK, Helsinki, Finland) uses 
geometrical and protocol parameters including the rotation angle. The 
two software use a mathematical phantom based on the Cristy’s 
hermaphrodite phantom, and dose calculation is based on the ICRP 
103 Report. 
Results: The percentage difference between the CBDI measured with 
the first and the second setup was 11%. MonteCarlo data showed an 
overall dose accuracy lower than 15%. An effective dose of 0.15 mSv 
for Protocol 1 and of 4.4 mSv for Protocol 2 was calculated with CT 
Dosimetry software. Using the PCXMC2.0 Rotation software it was 
obtained the same result for Protocol 1 and an effective dose of 3.2 
mSv for Protocol 2. We got quite similar results for organs at risk as 
reported in Table 1. 
 
  
Conclusions: CBCT imaging using cone beams adds a dose uniformly 
distributed over a wide field of view, often including OARs. Since 
radiotherapy CBCT imaging could be a daily practice, the imaging dose 
delivered to OARs can reach considerable values. Therefore this extra 
dose should be evaluated and taken into account in the overall 
treatment plan in order to report the real OARs dose.  
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Purpose/Objective: Cone Beam CT (CBCT) image quality is limited by 
the presence of scattered photons. Monte Carlo (MC) simulations 
provide a powerful tool for predicting patient specific scatter 
distributions. The time needed to perform such simulations can be a 
limiting factor preventing the use of MC simulations to correct for 
scattered photons in clinical CBCT imaging. This project investigates 
the feasibility of using a planning CT image to calculate the scattered 
photons that will be present in CBCT images acquired during 
radiotherapy. 
Materials and Methods: The EGSnrc user code egs_cbct was used to 
perform MC simulations predicting scatter distributions in a head, 
thorax and pelvis CBCT scan. Simulations were based on planning CT 
images, and the simulation setup was designed to mimic an Elekta XVI 
CBCT imaging system operated without a bowtie filter. A 
monoenergetic x-ray source was used, and air KERMA was scored for 
each projection image simulated in steps of 1.25 degrees. No 
downsampling of the planning CT images or the CBCT detector 
resolution was performed compared to the clinical setup used in our 
institution. Simulations were run on a 24 CPU cluster. 
Results: Taking advantage of the variance reduction techniques 
available in egs_cbct, scatter distributions can be predicted within 2% 
statistical uncertainty in less than 30 minutes for the head scan, 60 
minutes for the thorax scan and 120 minutes for the pelvis scan. 
Image quality is significantly improved in MC simulated CBCT images 
without scatter, compared to simulated CBCT images with scatter. 
The simulated number of histories, statistical uncertainties and 
simulation times are shown in the table. The reduced simulation time 
and statistical uncertainty in the head scan is due to the shorter path 
length and hence less attenuation of the x-rays compared to the 
larger patient volumes simulated in the thorax and pelvis scan. The 
denser pelvic region compared to the thorax requires the lengthiest 
simulations to compensate for the increased attenuation of x-rays. 
 
  
Conclusions: Recent MC software allows the prediction of patient 
specific scatter distributions in clinical CBCT imaging to be performed 
in a time frame enabling clinical applications. Simulations are based 
on planning CT images, and the varying simulation time for different 
anatomical regions is explained by variations in patient volume and 
density. MC simulations show a great potential for improved CBCT 
image quality if scattered photons can be removed more efficiently 
than the current clinical practice allows. For each patient, only one 
MC simulation is necessary to improve all CBCT images acquired during 
multiple radiotherapy fractions.  
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Purpose/Objective: Target registration errors after MR-CT-fusion are 
challenging to classify. The standard procedure in our clinic is to 
implant 4 gold fiducials in the prostate, and a MR-CT-fusion is then 
performed based on a rigid registration of the 4 gold fiducials. The 
implantation procedure states that the urologists should implant one 
apically, one centrally, and two in the base at different depths, 
guided by ultrasound. The implantation can be of mixed quality, and 
not all fiducials are implanted in the prostate. The aim of this study 
was to assess how the fiducial registration error (FRE) correlated with 
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the target registration, and we used the Dice similarity coefficient to 
classify the registration quality. A secondary aim was to find a FRE-
cutoff value that indicates a good MR-CT-fusion. A third aim was to 
see if there was an additional gain using 4 versus 3 gold fiducials in a 
rigid registration of the MR- and CT-series. 
Materials and Methods: Retrospectively we analysed 18 prostate 
patients treated with curative radiotherapy up to 78 Gy. All patients 
had 3 or 4 gold fiducials implanted in the prostate. All patients had 
performed MR-series within 1 hour after the CT-series, and the two 
series were fused through a rigid registration procedure in the dose 
planning system Oncentra (Elekta). Migration of the fiducials and 
deformation of the prostate can lead to an increased FRE. We 
simulated a systematic displacement of the most cranial fiducial. This 
influenced the fusion of CT- and MR-series, and the FRE and Dice 
similarity coefficients were compared. We simulated a systematic 
displacement in the X- and Y- direction of the fiducial of up to 4 mm. 
We also calculated a value that classified the spread of the fiducials in 
the prostate. The value is calculated from the sum of the distances 
between all the fiducials divided by the sum of the maximum distance 
between all the fiducials if they were located on the prostate wall. 
Results: We found that the spread of the fiducials is very important. A 
small FRE-value from fiducials that are closely spaced can hide a large 
target registration error. We found that a spread of the fiducials with 
a value of 0.6 of the maximum possible spread of fiducials in the 
prostate is a cut-off value that can be used to indicate that a small 
FRE correlates well with a good target registration. We found a clear 
indication that 4 fiducials give a better target registration than 3 
fiducials even when they indicate the same fiducial registration error. 
4 fiducials are more robust when it comes to errors from migration of 
the fiducials and deformation of the prostate. 
Conclusions: It is vital that the 4 fiducials implanted are well-spread 
in the prostate. A small FRE-value does not necessarily indicate a good 
target registration, and the FRE-value should be used in coherence 
with a value that indicates the spread of the fiducials. 4 fiducials are 
superior to 3 fiducials in most cases.  
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Purpose/Objective: Quality assurance for radiotherapy (QART) aims 
to improve patient outcome in Head and Neck (H&N) cancer patient 
included in prospective studies. Three levels of QART were proposed: 
center’s Facility Questionnaire and External Review Dosimetry 
Assessment with Dummy runs (QA level II), prospective Individual Case 
Reviews (ICRs) for 15% of patients (QA level III) and prospective ICRs 
for all patients (QA level IV). The purpose of this study is to assess the 
outcome impact (QAOI) and cost-effectiveness (QACEA) of the three 
levels of QART program, for H&N cancer patient included in the 
EORTC 22071-24071 protocol. 
Materials and Methods: The non-activated phase III of postoperative 
chemo-radiotherapy with EGFR inhibition would have included 600 
patients in 15 European centers. The study primary endpoint was 
local-tumor control on a two years follow-up, expressed as life-years 
without relapse. The follow-up of patients was modeled using a multi-
state model. Parameters of the model were derived from EORTC 
studies, TROG 0202 and RTOG 0525 prospective studies. Simulations 
were performed with a probabilistic sensitivity analysis. Results for 
each QART level were expressed as percentage of mortality and local 
failure on 2 years, and in survival times and life-days without relapse 
on 2 years.  
Results: For the QAOI, the estimated incremental percentage of local 
failure was -2.1% [95%CI: -5.9; -1.8], -4.9% [95%CI: -8.3; -1.5] and -
2.7% [95%CI: -4.6; -1.4], for an increase QART level from II to III, II to 
IV and III to IV, respectively. The estimated incremental survival times 
was 8 days [95%CI: -7; 24], 18 days [95%CI: 4; 34], and 10 days [95%CI: 
4; 18], for an increase QART level from II to III, II to IV and III to IV, 
respectively. The QACEA will be detailed during the congress. 
Conclusions: Patient treated with an increase QART level were 
significantly less likely to recur locally.  
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Purpose/Objective: Hypofractionated stereotactic ablative 
radiotherapy (SABR) for small volume lung tumours precisely delivers 
ablative doses using multiple fixed gantry angle beams or volumetric 
arc therapy (VMAT). The high dose per fraction can result in 
significant delivery times and flattening filter free (FFF) beams 
delivered at much higher dose rates may be advantageous. A study at 
our institution compared dose distributions and delivery accuracy of 
one and two arc VMAT plans created with standard and FFF beams to 
determine appropriate planning class solutions and verification 
methods for lung SABR treatments.  
Materials and Methods: Treatment plans were prepared on suitable 
lung datasets for SABR deliveries of 54Gy in 3 fractions. One and two 
arc VMAT plans were optimised and calculated for standard 6MV 
beams (600MU/min) and 6MV FFF beams (1400MU/min). Analysis of 
the resulting dose distributions included conformity index and organ 
at risk (OAR) doses. Deliveries were verified by in-phantom point dose 
measurements and fluence measurements in 2 dose planes using a 2D 
ion chamber array. 
Results: Plans comprised a single 360° arc or two co-planar 195°arcs 
orientated to avoid the contra-lateral lung. All resulting dose 
distributions satisfied pre-defined dose and dose volume constraints 
when using the same optimisation objectives and priorities regardless 
of energy or beam arrangement. There was a slight improvement in 
conformity index with the FFF energy. The two arc technique resulted 
in lower mean and maximum doses to the contra-lateral lung however 
there was no significant difference in V20Gy and V12.5Gy for the 
combined lung. Total beam on time was approximately 5.6 minutes 
for 6MV and 2.5 minutes for 6MV FFF. Target volume point dose 
measurements in geometrical and semi-anatomical phantoms were 
within 2.5% of calculated for all deliveries. Measured point doses 
outside the target volumes were up to 6.5% different to calculated 
however dose gradients in these low dose regions may have 
contributed to the higher discrepancies. Fluence measurements with a 
2D ion chamber array showed 100% of points within the 3%/3mm dose 
difference / distance to agreement threshold for points above 20% of 
the maximum dose.  
Conclusions: Class solutions for one and two arc VMAT deliveries 
resulting in acceptable dose distributions for SABR lung treatments 
can be achieved with 6MV and 6MV FFF beams. Analysis of the 
resultant dose distributions showed no significant differences between 
plans. There was good agreement between planned and delivered 
point doses within the target volumes and OARs and between planned 
and delivered fluence regardless of beam orientation or energy. FFF 
deliveries are significantly faster than standard which may improve 
the patient experience. The choice of single arc or two arc plans is 
dependant on isocentre position in order to avoid collision as the 
gantry rotates around the patient. 
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Purpose/Objective: To assess the accuracy of plastic scintillation 
detectors (PSDs) for real time in-vivo measurement of the dose to the 
anterior rectal wall for IMRT and to determine the clinical utility of 
daily monitoring of rectal dose for prostate cancer patients. 
Materials and Methods: 58 in-vivo measurements were performed 
during prostate IMRT for the 1st two patients of an IRB approved 
protocol. During each monitored fraction two PSDs were attached to 
the anterior surface of an endorectal balloon to monitor the dose 
delivered to the rectal wall. The balloon was inserted into the patient 
